Home Sleep Apnea Test Market Size, Share & Trends Analysis Report By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa), And Segment Forecasts, 2024 - 2030

Home Sleep Apnea Test Market Trends

The global home sleep apnea test market size was estimated at USD 2.18 billion in 2023 and is expected to grow at a CAGR of 6.4% from 2024 to 2030. The market growth is attributed to the increasing prevalence of sleep apnea and growing initiatives by government and market players aimed at increasing awareness of the benefits associated with HSAT in sleep apnea treatment. For instance, as of May 2024, data from the National Council on Aging indicates that approximately 39 million adults in the U.S. and an estimated 936 million adults worldwide are affected by Obstructive Sleep Apnea (OSA). In addition, advancements in Home Sleep Apnea Tests (HSATs) are expected to drive market growth over the forecast period.

The prevalence of sleep apnea among the elderly remains largely undiagnosed due to limited awareness and non-specific symptoms. With the global population aged 60 and older expected to reach 2 billion by 2050, and the proportion of this age group projected to increase from 12% to 22%, there is an anticipated rise in sleep disorders, particularly Obstructive Sleep Apnea (OSA). OSA is estimated to affect between 13% and 32% of individuals over the age of 65. This growing incidence among the aging population is likely to drive increased demand for advanced home sleep apnea tests (HSATs).

The COVID-19 pandemic significantly accelerated the adoption of HSATs due to concerns about in-person healthcare interactions and the need for remote medical solutions. With many sleep centers temporarily closed or operating at reduced capacity, patients and providers turned to HSATs as a safer and more convenient alternative. The surge in demand for telemedicine and remote monitoring technologies highlighted the efficacy and reliability of HSATs. Insurance companies and healthcare providers began to recognize their value, leading to expanded coverage and acceptance. The pandemic also spurred advancements in HSAT technology, enhancing diagnostic accuracy and user experience.

A survey conducted by Itamar Medical and Sleep Medicine Publication in March 2021 found that 67% of clinics reported a moderate to significant decrease in patients undergoing polysomnography (PSG), while 66% observed a moderate to significant increase in the use of HSATs. Additionally, 65% of these clinics anticipate that HSATs will continue to be preferred over PSG as the primary diagnostic method for sleep apnea even after the pandemic.

Market Concentration and Characteristics

The market is experiencing a high degree of innovation driven by advancements in sensor technology, data analytics, and AI integration. In March 2022, Infineon Technologies AG partnered with Sleepiz AG to offer a solution for simplified sleep monitoring within the home environment. This system is compatible with various connected smart home devices, including smart speakers and bedside lamps. Utilizing Infineon's XENSIV 60 GHz radar technology alongside Sleepiz's established algorithms, this solution targets customers aiming to serve the wider consumer market.

The level of M&A activities in the market is moderate, with mature players acquiring emerging companies to enhance their market position. For example, in October 2021, ZOLL Medical Corporation acquired Itamar Medical Ltd., a company known for integrating sleep apnea diagnostics within cardiac patient care. The acquisition was valued at approximately USD 538 million and included all outstanding ordinary shares of Itamar Medical.

Increasing government support through approvals is driving market players to invest in technological advancements and expansion strategies. For instance, in April 2022, Onera Health's at-home sleep diagnostic system, Onera STS, received FDA clearance and was launched in the U.S. market in 2023. This patch-based technology aims to modernize traditional sleep testing by providing a clinical-grade, end-to-end polysomnography (PSG) service via its digital health platform. The system's approval underscores its equivalency to established in-lab devices such as those from Natus Medical.

Geographical expansion is fueling market growth by increasing access to advanced home sleep apnea tests (HSATs). This expansion fosters international partnerships and integrates innovative healthcare technologies across various regions, leading to quicker adoption of HSATs. For instance, in May 2023, UK-based medical device company Acurable introduced its AcuPebble device for diagnosing obstructive sleep apnea in the U.S. market, following FDA clearance.

Regional Insights

North America home sleep apnea test market dominated and accounted for the largest revenue share of 47.74% in 2023. Factors such as evolving lifestyles increased disposable incomes, the involvement of leading industry participants, a higher rate of obesity, a rising incidence of respiratory conditions, enhanced recognition of Obstructive Sleep Apnea (OSA), and supportive government policies are fueling the market growth.

U.S. Home Sleep Apnea Test Market Trends

The home sleep apnea test market in the U.S. accounted for the largest share in 2023. One of the key factors driving the market growth is initiatives such as expansions undertaken by market players in the country. For instance, in March 2023 Sunrise, a Belgium based company, after obtaining clearance from the US Food and Drug Administration for its second-generation chin patch sleep test device and securing a funding round of USD 18.2 million, plans to introduce its home sleep test in the U.S. market.

Canada home sleep apnea test market’s growth in the country is driven by increasing awareness regarding the benefits associated with adoption of HSAT. Thus, key players in the market are investing in expansion strategies to strengthen their market position. For instance, Nox Medical has established Nox Medical Canada Inc., its physical operation within Canada aimed at optimizing the distribution network for sleep testing equipment. This expansion is in response to the substantial increase in sleep diagnostic sales observed in 2023, with the objective of improving logistical efficiency and customer service for healthcare providers in Canada.

Asia Pacific Home Sleep Apnea Test Market Trends

The home sleep apnea test market in Asia Pacific is expected to register the fastest growth rate over the forecast period. The growth is attributed to the significant adoption of technologically advanced HSATs. Moreover, increasing prevalence of sleep apnea along with initiatives from the government and private entities are anticipated to fuel the demand for HSAT over the forecast period.

China home sleep apnea test market held a significant revenue share in the region in 2023. The increasing technological advancements in the market are fueling the market growth. For instance, in April 2024, Researchers at the Sleep Medicine Center of China Medical University Hospital in Taiwan have been developing the iDREAM home sleep test. The development has involved clinical trials with over 100 patients, utilizing AI-enhanced ECG analysis to improve the accuracy of obstructive sleep apnea diagnoses, simultaneously streamlining diagnostic and treatment processes. iDREAM promises to mitigate challenges associated with limited sleep center capacities and staffing constraints by offering a comprehensive, efficient solution for sleep apnea monitoring. Ongoing clinical evaluations are in place, aiming for certification and incorporation into clinical settings.

The home sleep apnea test market in India is driven by the increasing number of initiatives aimed at increasing awareness regarding sleep apnea, from the government and key market players. For instance, in August 2022, ResMed, a provider of digital health solutions and connected devices for sleep and respiratory care, initiated a campaign titled ‘#AwakenYourBest’. This initiative seeks to raise awareness of sleep disorders and the importance of appropriate care. ‘#AwakenYourBest’ focuses on reducing the stigma associated with sleep apnea and promoting awareness about the benefits of sleep therapy and related devices for managing this condition.

Key Home Sleep Apnea Test Company Insights

Key companies are adopting strategies such as mergers and acquisitions, product and service launches, agreements, joint ventures, collaborations, and expansion to strengthen their position in the market.

Recent Developments

• In December 2023, Compumedics Limited obtained approval from the U.S. Food and Drug Administration for marketing its Somfit device in the U.S. This represents a critical strategic advancement for the Somfit technology platform within the U.S. sleep market.

• In July 2023, Compumedics Limited has entered into a preliminary distribution agreement with CPAP Direct for the sale of Somfit and Somfit Pro, alongside ongoing services and supplies in Queensland.

• In October 2021, ResMed announced the acquisition of Ectosense, a key player in the market for cloud-connected home sleep test (HST) devices. This acquisition is significant as Ectosense's products, particularly the FDA-approved NightOwl, are critical in diagnosing sleep apnea, a condition often undiagnosed yet affecting millions globally.

Home Sleep Apnea Test Market Report Scope

Global Home Sleep Apnea Test Market Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global home sleep apnea test market report based on region:

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait